PTP1B contributes to calreticulin-induced metastatic phenotypes in esophageal squamous cell carcinoma

Molecular Cancer Research

Volumn 11, Issue 9, 2013, Pages 986-994

  Wang, Xiao Min ^a   Shang, Li ^a   Zhang, Yu ^a   Hao, Jia Jie ^a   Shi, Feng ^a   Luo, Wei ^a   Zhang, Tong Tong ^a   Wang, Bo Shi ^a   Yang, Yang ^a   Liu, Zhi Hua ^a   Zhan, Qi Min ^a   Wang, Ming Rong ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CALRETICULIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN TYROSINE PHOSPHATASE 1B; STAT5A PROTEIN;

ARTICLE; CANCER GROWTH; CANCER PATIENT; CANCER TISSUE; CELL MIGRATION; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG METASTASIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION;

ANIMALS; CALRETICULIN; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL MOVEMENT; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; LUNG NEOPLASMS; MICE; MICE, SCID; MOLECULAR TARGETED THERAPY; PHENOTYPE; PHOSPHORYLATION; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1; RNA, MESSENGER; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEINS;

EID: 84884498187     PISSN: 15417786     EISSN: 15573125     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-12-0704     Document Type: Article

References (21)

1. Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med 2003; 349:2241-52. (Pubitemid 37485141)
2. Wang LS, Chow KC, Chi KH, Liu CC, Li WY, Chiu JH, et al. Prognosis of esophageal squamous cell carcinoma: analysis of clinicopathological and biological factors. Am J Gastroenterol 1999;94:1933-40.
3. Du XL, Yang H, Liu SG, Luo ML, Hao JJ, Zhang Y, et al. Calreticulin promotes cell motility and enhances resistance to anoikis through STAT3-CTTN-Akt pathway in esophageal squamous cell carcinoma. Oncogene 2009;28:3714-22.
4. Michalak M, Groenendyk J, Szabo E, Gold LI, Opas M. Calreticulin, a multi-process calcium-buffering chaperone of the endoplasmic reticulum. Biochem J 2009;417:651-66.
5. Orr AW, Elzie CA, Kucik DF, Murphy-Ullrich JE. Thrombospondin signaling through the calreticulin/LDL receptor-related protein cocomplex stimulates random and directed cell migration. J Cell Sci 2003;116(Pt 14):2917-27. (Pubitemid 36926981)
6. Orr AW, Pallero MA, Xiong WC, Murphy-Ullrich JE. Thrombospondin induces RhoA inactivation through FAK-dependent signaling to stimulate focal adhesion disassembly. J Biol Chem 2004;279:48983-92. (Pubitemid 39625780)
7. Hayashida Y, Urata Y, Muroi E, Kono T, Miyata Y, Nomata K, et al. Calreticulin represses E-cadherin gene expression in Madin-Darby canine kidney cells via Slug. J Biol Chem 2006;281:32469-84. (Pubitemid 46036802)
8. Chen CN, Chang CC, Su TE, Hsu WM, Jeng YM, Ho MC, et al. Identification of calreticulin as a prognosis marker and angiogenic regulator in human gastric cancer. Ann Surg Oncol 2009;16:524-33.
9. Lu YC, Chen CN,WangB,HsuWM,Chen ST, Chang KJ, et al. Changes in tumor growth and metastatic capacities of J82 human bladder cancer cells suppressed by down-regulation of calreticulin expression. Am J Pathol 2011;179:1425-33.
10. Du XL, Hu H, Lin DC, Xia SH, Shen XM, Zhang Y, et al. Proteomic profiling of proteins dysregulated in Chinese esophageal squamous cell carcinoma. J Mol Med (Berl) 2007;85:863-75. (Pubitemid 47077107)
11. Imanaka Y, Tsuchiya S, Sato F, Shimada Y, Shimizu K, Tsujimoto G. MicroRNA-141 confers resistance to cisplatin-induced apoptosis by targeting YAP1 in human esophageal squamous cell carcinoma. J Hum Genet 2011;56:270-6.
12. Wu M, Massaeli H, Durston M, Mesaeli N. Differential expression and activity of matrix metalloproteinase-2 and -9 in the calreticulin deficient cells. Matrix Biol 2007;26:463-72. (Pubitemid 47086374)
13. Wiener JR, Hurteau JA, Kerns BJ, Whitaker RS, Conaway MR, Berchuck A, et al. Overexpression of the tyrosine phosphatase PTP1B is associated with human ovarian carcinomas. Am J Obstet Gynecol 1994;170:1177-83. (Pubitemid 24157935)
14. Wiener JR, Kerns BJ, Harvey EL, Conaway MR, Iglehart JD, Berchuck A, et al. Overexpression of the protein tyrosine phosphatase PTP1B in human breast cancer: association with p185c-erbB-2 protein expression. J Natl Cancer Inst 1994;86:372-8.
15. Lessard L, Labbe DP, Deblois G, Begin LR, Hardy S, Mes-Masson AM, et al. PTP1B is an androgen receptor-regulated phosphatase that promotes the progression of prostate cancer. Cancer Res 2012;72:1529-37.
16. Wang J, Liu B, Chen X, Su L, Wu P, Wu J, et al. PTP1B expression contributes to gastric cancer progression. Med Oncol 2012;29:948-56.
17. Zhu S, Bjorge JD, Fujita DJ. PTP1B contributes to the oncogenic properties of colon cancer cells through Src activation. Cancer Res 2007;67:10129-37. (Pubitemid 350070784)
18. Ihle JN. The Stat family in cytokine signaling. Curr Opin Cell Biol 2001;13:211-7. (Pubitemid 32209222)
19. Darnell JE Jr. STATs and gene regulation. Science 1997;277:1630-5. (Pubitemid 27446219)
20. Gouilleux F, Wakao H, Mundt M, Groner B. Prolactin induces phosphorylation of Tyr694 of Stat5 (MGF), a prerequisite for DNA binding and induction of transcription. EMBO J 1994;13:4361-9. (Pubitemid 24295208)
21. Si J, Collins SJ. Activated Ca2+/calmodulin-dependent protein kinase IIgamma is a critical regulator of myeloid leukemia cell proliferation. Cancer Res 2008;68:3733-42.